XT
The startup develops a proprietary medical treatment technology that enhances sperm production and function through a single injection, demonstrated in preclinical and randomized clinical trials involving infertile men. This approach directly addresses male infertility by providing a targeted solution for patients seeking effective treatment options.
Updated 3 months ago
Funding
$510K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a proprietary medical treatment technology that enhances sperm production and function through a single injection, demonstrated in preclinical and randomized clinical trials involving infertile men. This approach directly addresses male infertility by providing a targeted solution for patients seeking effective treatment options.